Form 4 for COYA Coya Therapeutics, Inc.
Accepted 2024-11-14 00:00:00 ET · period of report 2024-11-14 · accession 0001493152-24-046106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-14 | 2024-11-14 | COYA | SNYDER DAVID S | CFO | P - Purchase | $7.19 | +1,800 | 8,800 | +26% | +$12.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2024-11-14 | P | A | 1,800 | $7.19 | 8,800 | D | — | — |